Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole
NCT ID: NCT00485199
Last Updated: 2007-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
231 participants
INTERVENTIONAL
2005-01-31
2006-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In 1982, Gonvers and Machemer4 proposed a new treatment technique that combined pars plana vitrectomy (PPV), partial air-fluid exchange, and face down positioning for 24 hours. Since then vitrectomy with gas tamponade become the most common procedure for retinal detachment with macular hole.
In 1984, Miyake performed a simple gas injection into the vitreous followed by a face-down position. The effective of this simplified method was then reported by many observers.But these studies may have insufficiency because of small sample, nonrandomized, no defined eligibility criteria for patients selection.
Intraocular gas tamponade with or without pars plana vitrectomy (PPV) has commonly been performed nowadays. We conducted a multicenter randomized controlled clinical trial to compare their anatomic results and visual outcomes of both surgical techniques, to estimate the efficiency of both surgical methods in the treatment of retinal detachment with myopic macular hole.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pneumatic Retinopexy
Vitrectomy with Gas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The ability to give informed consent and to return for follow-up visit for 12 months
Exclusion Criteria
* retinal detachment with severe proliferative vitreoretinopathy
* retinal detachment with choroidal detachment or rupture
* traction retinal detachment due to retinal vascular disease
* had vitrectomy in the past
* macular hole without retinal detachment
* foveal schiesis without retinal detachment
* secondary macular hole with retinal detachment
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiaoxin Li, professor
Role: STUDY_CHAIR
Peking University
Jialiang Zhao, professor
Role: PRINCIPAL_INVESTIGATOR
Eye Institute of Peking Union Hospital, Peking Union Medical College
Wenji Wang, professor
Role: PRINCIPAL_INVESTIGATOR
Department of ophthalmology of Eye Ear Nose Throat Hospital, Fudan University, Shanghai
Shibo Tang, professor
Role: PRINCIPAL_INVESTIGATOR
Zhong Shan Ophthalmic Center, Sun Yat-sen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of ophthalmology of People Hospital, Peking University
Beijing, Beijing Municipality, China
Department of ophthalmology of Beijing Hospital
Beijing, Beijing Municipality, China
Department of ophthalmology of Beijing Tong Ren Hospital
Beijing, Beijing Municipality, China
Department of ophthalmology of China PLA General Hospital
Beijing, Beijing Municipality, China
Peking Eye Center of the third affiliated Hospital of Peking University
Beijing, Beijing Municipality, China
Zhong Shan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China
Department of ophthalmology of The Second affiliated Xiang Ya Hospital, Central South University
Changsha, Hunan, China
Department of ophthalmology of The First affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Department of ophthalmology of The First affiliated Hospital of China Medical University
Shenyang, Liaoning, China
Shandong Eye Institute
Qingdao, Shandong, China
Department of ophthalmology of EENT Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Department of ophthalmology of The First affiliated People Hospital of Shang Hai Jiao Tong University
Shanghai, Shanghai Municipality, China
Department of ophthalmology of West China Hospital, Sichuan University
Chengdu, Sichuan, China
Tianjin Eye Hospital
Tianjin, Tianjin Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Schwartz SG, Flynn HW Jr, Wang X, Kuriyan AE, Abariga SA, Lee WH. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy. Cochrane Database Syst Rev. 2020 May 13;5(5):CD006126. doi: 10.1002/14651858.CD006126.pub4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RDMH2007-china
Identifier Type: -
Identifier Source: org_study_id